Detail page

Knowledge Web

Person

Thomas Worst (1985-)

Arzt

Name	Thomas Worst
Time	1985- (Date of birth and death)
Place	Mannheim (Geburtsort) Deutschland
Academic degree	Dr. med.
Profession	Arzt (characteristic profession)
Variant	T. Worst Thomas Stefan Worst Thomas S. Worst T. S. Worst
Further information	Diss. Fachbereich Medizin der Univ. Frankfurt (Main); Assistenzarzt in der Urologischen Klinik der Medizinischen Fakultät Mannheim der Universität Heidelberg
Record type	Person
GND-Identifier	1028335679
Record ID	1028335679
Involved in show all Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort Immuntherapien in der Uroonkologie : Ansprechen und Therapieunterbrechungen durch Nebenwirkungen in einer bizentrischen Real-world-Analyse Deep learning can predict survival directly from histology in clear cell renal cell carcinoma Peritoneal flap for lymphocele prophylaxis following robotic-assisted laparoscopic radical prostatectomy with pelvic lymph node dissection: study protocol and trial update for the randomized controlled PELYCAN study Inter-Laboratory Comparison of Extracellular Vesicle Isolation Based on Ultracentrifugation Contemporary outcomes after transurethral procedures for bladder neck contracture following endoscopic treatment of benign prostatic hyperplasia Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer Urologische Forschung in Deutschland : Eine retrospektive, longitudinale Beobachtungsstudie Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5 ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making FOXM1 predicts disease progression in non-muscle invasive bladder cancer Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients The EEF1A2 gene expression as risk predictor in localized prostate cancer Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review Modernes Netzwerken : Thematische Ausrichtungen in der Arbeitsgruppe „Blasenkarzinom Experimentell“ der GeSRU Academics Mikrowellenablation bei primären und sekundären Lungenmalignomen : Verlaufsbeobachtung und Evaluation von Prognosefaktoren für die lokale Tumorprogression

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Thomas Worst (1985-)

Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis

A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma

Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy

Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort

Immuntherapien in der Uroonkologie : Ansprechen und Therapieunterbrechungen durch Nebenwirkungen in einer bizentrischen Real-world-Analyse

Deep learning can predict survival directly from histology in clear cell renal cell carcinoma

Peritoneal flap for lymphocele prophylaxis following robotic-assisted laparoscopic radical prostatectomy with pelvic lymph node dissection: study protocol and trial update for the randomized controlled PELYCAN study

Inter-Laboratory Comparison of Extracellular Vesicle Isolation Based on Ultracentrifugation

Contemporary outcomes after transurethral procedures for bladder neck contracture following endoscopic treatment of benign prostatic hyperplasia

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer

The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery

Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer

Urologische Forschung in Deutschland : Eine retrospektive, longitudinale Beobachtungsstudie

Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making

FOXM1 predicts disease progression in non-muscle invasive bladder cancer

Economy of Standards: European Association of Urology Guideline Changes Influence Treatment Costs in Stage I Testicular Cancer Patients

Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer

High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients

The EEF1A2 gene expression as risk predictor in localized prostate cancer

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review

Modernes Netzwerken : Thematische Ausrichtungen in der Arbeitsgruppe „Blasenkarzinom Experimentell“ der GeSRU Academics

Mikrowellenablation bei primären und sekundären Lungenmalignomen : Verlaufsbeobachtung und Evaluation von Prognosefaktoren für die lokale Tumorprogression